| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $33,062,746 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA239227 | FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers | 000 | 5 | NIH | 11/29/2023 | $357,936 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA058018 | Gabapentinoid/opioid mixtures: abuse and toxicity | 000 | 2 | NIH | 1/16/2024 | $357,064 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32DK134051 | Osteocytic Connexin 43 Hemichannel Regulation of Adiposity | 000 | 2 | NIH | 12/13/2023 | $74,492 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI172207 | Translational Regulation of Candida glabrata Azole Resistance | 000 | 2 | NIH | 12/7/2023 | $209,250 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031352 | Evaluation of the Role of Macrophage Migratory Inhibitory Factor (MIF) in mediating Stem Cell Analgesia in a Model of Orofacial Pain | 000 | 2 | NIH | 11/29/2023 | $417,454 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA269866 | Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma | 001 | 2 | NIH | 4/17/2024 | $26,448 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA269866 | Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma | 000 | 2 | NIH | 12/14/2023 | $476,077 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21MH129960 | Behavioral state-dependent microglia Ca2+ dynamics | 000 | 2 | NIH | 12/29/2023 | $174,375 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | K01NS126489 | Delineating the role of the gut microbiota and its derived metabolites in the development of dementia in multi-ethnic populations | 001 | 2 | NIH | 1/19/2024 | $220,142 |
| | 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R18HS027756 | Dissemination and implementation of a telehealth program to deliver effective antibiotic stewardship support to rural or medically underserved newborn nurseries. | 000 | 3 | AHRQ | 1/30/2024 | $342,216 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA262657 | Improving Therapeutic Approaches for RAS-driven Embryonal Rhabdomyosarcoma | 001 | 3 | NIH | 4/17/2024 | $17,729 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA262657 | Improving Therapeutic Approaches for RAS-driven Embryonal Rhabdomyosarcoma | 000 | 3 | NIH | 1/22/2024 | $319,106 |
| | 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH127216 | Neural connectivity before and after each of the three treatment phases of trauma-focused therapy for adolescent posttraumatic stress | 000 | 3 | NIH | 2/8/2024 | $697,548 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL158081 | Role of BRD4 in Normal Hematopoiesis and Hematopoietic Stem Cell Biology | 000 | 3 | NIH | 11/24/2023 | $310,000 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG075703 | Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease | 000 | 3 | NIH | 3/14/2024 | $582,280 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 000 | 3 | NIH | 3/19/2024 | $251,756 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262041 | Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients | 000 | 4 | NIH | 4/12/2024 | $324,702 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK128247 | The Regulation of Hepatic Metabolic Zonation by the Diabetes Gene TCF7L2 | 000 | 3 | NIH | 12/18/2023 | $440,457 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 000 | 3 | NIH | 11/30/2023 | $652,130 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 001 | 3 | NIH | 4/17/2024 | $31,777 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI161363 | Mechanism-based targeting of the RNA processing machinery of SARS-CoV-2- | 000 | 3 | NIH | 2/22/2024 | $172,636 |
| | 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM141091 | Genome Maintenance via the BRCA-RAD54 Axis | 000 | 4 | NIH | 2/13/2024 | $292,950 |
| | 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM141091 | Genome Maintenance via the BRCA-RAD54 Axis | 001 | 4 | NIH | 2/14/2024 | $22,116 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA257391 | PAI-1-mediated early-onset endometrial cancer | 000 | 4 | NIH | 4/9/2024 | $424,546 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA246807 | Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy | 001 | 4 | NIH | 4/17/2024 | $17,834 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA246807 | Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy | 000 | 4 | NIH | 2/29/2024 | $320,992 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA257148 | Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy | 001 | 4 | NIH | 4/17/2024 | $19,190 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA257148 | Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy | 000 | 4 | NIH | 2/22/2024 | $345,411 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK138035 | Paracrine effects of leptin in regulating visceral fat expansion | 000 | 1 | NIH | 3/15/2024 | $387,500 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AA031407 | Deciphering RNA Splicing Control of Lipid Metabolism and Alcoholic Liver Injury | 000 | 1 | NIH | 2/29/2024 | $504,482 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI177345 | Lymphoid residency of Tcf-1+ CD8+ T cells during tumor vaccine responses | 000 | 1 | NIH | 2/5/2024 | $397,441 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS131652 | CB1 receptors mediate metaplasticity in the cerebellar circuit | 000 | 1 | NIH | 2/29/2024 | $407,189 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R13CA287954 | Advancing the Science of Cancer in Latinos 2024 | 000 | 1 | NIH | 2/20/2024 | $10,000 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30MH134482 | Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders | 001 | 1 | NIH | 3/11/2024 | $0 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30MH134482 | Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders | 000 | 1 | NIH | 3/11/2024 | $40,231 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA277399 | Development of a new class of EZH2 inhibitors in ERa-negative breast cancer. | 000 | 1 | NIH | 12/20/2023 | $213,194 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG061729 | Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimer?s disease | 000 | 2 | NIH | 3/7/2024 | $564,248 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HS029891 | Evaluation of Post-Acute Care Access and Outcomes: Influence of Social Determinants of Health on Urban and Rural Rehabilitation Service Areas Before and After COVID-19 | 000 | 1 | AHRQ | 2/26/2024 | $394,886 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM153228 | Mechanisms of enhancer dynamics and assembly in gene regulation | 000 | 1 | NIH | 3/11/2024 | $387,508 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 001 | 1 | NIH | 2/1/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 000 | 1 | NIH | 12/20/2023 | $37,034 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS132778 | Interrogating the role of LRP1 subdomains in neural stem cell function | 001 | 1 | NIH | 1/13/2024 | $46,538 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD108124 | The genome integrity and epigenome of sperm from men with recurrent pregnancy loss | 000 | 2 | NIH | 3/15/2024 | $576,629 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG081422 | Cardiolipin Remodeling in Alzheimer?s Disease | 000 | 2 | NIH | 4/17/2024 | $339,063 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA279667 | Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to enhance MRI diagnostic capabilities in Prostate Cancer | 001 | 2 | NIH | 4/18/2024 | $28,698 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA279667 | Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to enhance MRI diagnostic capabilities in Prostate Cancer | 000 | 2 | NIH | 3/26/2024 | $516,598 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA277498 | Novel approach of targeting AT-rich S/MAR regions for treating therapy resistant breast cancers | 000 | 2 | NIH | 4/16/2024 | $459,961 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 000 | 2 | NIH | 2/23/2024 | $475,723 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG082360 | The San Antonio Heart and Mind Study | 000 | 2 | NIH | 3/13/2024 | $3,220,614 |
|
